Selected Multi-phase Treatment For Coronavirus Respiratory Infections
A multi-phase treatment of a respiratory disease in which one treatment is a lysing defense by applying inhibitory agents to respiratory passages. Application may be by nasal irrigant, oral gargling mouthwash, or smelling salt. Another treatment is an immune system suppressing defense by providing a liposome-based countermeasure to excess activity of the host immune system during COVID-19 infection. The liposome increases bio-activity of probiotics, probiotics-produced therapeutic peptides, bio-peptides, and antioxidant level in the blood with a sustained massive dose of antioxidants to counteract excess oxidation produced by excess activity of the host immune system, when administered through oral route.
Claim CLM-00001. 1. A method of treating SARS-CoV-2 coronavirus infection by administering to a human subject in need thereof an effective amount of a preparation of:
a combination of viable probiotics comprising Lactococcus lactis subsp. lactis, Lactobacillus sporogenes, Streptococcus thermophilus; and immunomodulins of said viable probiotics.
Claim CLM-00009. 9. A method of treating SARS-CoV-2 coronavirus infection by administering to a subject in need thereof, said subject chosen among human, dog, or cat, an effective amount of a preparation comprising:
a liposome of a viable probiotic, wherein the said viable probiotic is a combination of Lactococcus lactis subsp. lactis, Lactobacillus sporogenes, and Streptococcus thermophilus, and immunomodulins of said viable probiotic.
